01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1054 25 1304 108 1315 189 1151
ERLYTX 81 1 52 3 37 6 37
GI 185 3 157 11 134 20 122
GU 412 4 209 23 280 48 292
LEUK 136 1 52 7 85 18 110
LUNG 178 3 157 15 183 34 207
LYMPH 394 8 417 28 341 48 292
MELAN 262 0 0 0 0 1 6
MMYEL 120 2 104 6 73 13 79
MULT 23 0 0 1 12 5 30
OTHER 41 2 104 5 61 7 43
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2890 49 2556 207 2521 389 2369

01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 122 4 209 18 219 30 183
ERLYTX 10 0 0 0 0 0 0
LEUK 639 13 678 54 657 99 603
LUNG 324 7 365 29 353 60 365
OTHER 36 0 0 1 12 4 24
PEOLC 124 0 0 1 12 13 79
PREV 221 9 470 25 304 49 298
SURV 18 0 0 0 0 1 6
SXQOL 541 10 522 39 475 75 457
Total 2035 43 2244 167 2032 331 2015

01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1054 25 1304 108 1315 189 1151
CCD 122 4 209 18 219 30 183
ERLYTX 91 1 52 3 37 6 37
GI 185 3 157 11 134 20 122
GU 412 4 209 23 280 48 292
LEUK 775 14 730 61 743 117 712
LUNG 502 10 522 44 536 94 572
LYMPH 394 8 417 28 341 48 292
MELAN 262 0 0 0 0 1 6
MMYEL 120 2 104 6 73 13 79
MULT 23 0 0 1 12 5 30
OTHER 77 2 104 6 73 11 67
PEOLC 124 0 0 1 12 13 79
PREV 223 9 470 25 304 49 298
SURV 18 0 0 0 0 1 6
SXQOL 543 10 522 39 475 75 457
Total 4925 92 4800 374 4554 720 4383

01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 681 16 835 83 1011 135 822
ERLYTX 44 0 0 1 12 3 18
GI 131 1 52 6 73 11 67
GU 345 2 104 19 231 41 250
LEUK 82 1 52 6 73 14 85
LUNG 114 3 157 10 122 20 122
LYMPH 253 5 261 16 195 29 177
MELAN 166 0 0 0 0 1 6
MMYEL 74 1 52 4 49 9 55
MULT 8 0 0 0 0 1 6
OTHER 40 1 52 4 49 6 37
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1942 30 1565 149 1815 270 1645

01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 109 4 209 17 207 27 164
ERLYTX 10 0 0 0 0 0 0
LEUK 271 6 313 22 268 38 231
LUNG 203 4 209 13 158 34 207
OTHER 36 0 0 1 12 4 24
PEOLC 87 0 0 1 12 11 67
PREV 221 9 470 25 304 49 298
SURV 18 0 0 0 0 1 6
SXQOL 369 8 417 33 402 56 341
Total 1324 31 1618 112 1363 220 1338

01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 874 21 1096 104 1266 169 1029
CCD 146 5 261 21 256 30 183
ERLYTX 54 0 0 1 12 3 18
GI 136 2 104 7 85 12 73
GU 368 3 157 23 280 46 280
LEUK 353 7 365 28 341 52 317
LUNG 324 9 470 27 329 60 365
LYMPH 253 5 261 16 195 29 177
MELAN 166 0 0 0 0 1 6
MMYEL 65 1 52 4 49 9 55
MULT 27 1 52 3 37 6 37
OTHER 246 1 52 14 170 31 189
PEOLC 90 0 0 3 37 12 73
PREV 223 9 470 25 304 49 298
SURV 18 0 0 0 0 1 6
SXQOL 371 8 417 33 402 56 341
Total 3714 72 3757 309 3763 566 3447

01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 867 24 1252 77 937 137 834
ERLYTX 77 1 52 3 37 6 37
GI 109 2 104 7 85 12 73
GU 248 2 104 14 170 37 225
LEUK 104 1 52 4 49 10 61
LUNG 141 3 157 12 146 28 170
LYMPH 321 6 313 23 280 40 244
MMYEL 107 2 104 4 49 11 67
MULT 23 0 0 1 12 5 30
Total 1997 41 2138 145 1765 286 1741

01-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1906 28 1461 143 1741 278 1692
AFFIL 140 6 313 17 207 37 225
CCOP/NCORP 1220 27 1409 101 1230 175 1065
Non-SWOG 1656 28 1461 110 1339 227 1382
Total 4922 89 4644 371 4517 717 4364

01-FEB-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 Y 28-JAN-26

01-FEB-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2210 Pros, High Risk, BRCA, Neoadj Carbo 1 T 21-JAN-26
GU S2200 pRCC, Adv, Cabo ± Atezo 1 T 16-JAN-26
MELAN EA6141 Melan, Adv, Nivolumab+Ipi ± Sargmostim 1 E 08-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 1 E 07-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 2 E 07-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 0 E 05-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 1 E 05-JAN-26

01-FEB-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 19
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 13
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 12
LUNG LUNGMAP NSCLC, Adv, Master 1 7
PREV A212102 Blind Ref Set for Multicancer Early Detection 1 6
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 5
LUNG LUNGMAP NSCLC, Adv, Master 2 4
LUNG S2409 ESCLC, Durvalumab +/- Biomarker Directed Tx 1 4
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 4
LYMPH AHOD2131 cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 2 3
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 3
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 3
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 3